Bristol Myers Squibb

NULOJIX

Manufacturer:

Bristol Myers Squibb

Nulojix HCPCS:

J0485

HCPCS Code Descriptor:

Injection, belatacept, 1 mg

Category:

J Code

Nulojix NDCs:

00003-0371-13

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Nulojix CPT Codes:

Potential CPT administration codes for Nulojix can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Nulojix:

NULOJIX is an Immunosuppressant drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J0485 is aligned to the drug NULOJIX.

Nulojix is a type of drug called a selective immunosuppressant. Nulojix is prescribed to patients who have recently received a new organ via transplant, such as a kidney. Nulojix is thought to work by weakening the immune system slightly. This prevents the body from attacking and rejecting the new organ. This increases the chances of a successful transplant.

ACCESS PRICING AND MORE BY REGISTERING

J0485 Added Date:

January 1, 2013

J0485 Effective Date:

January 1, 2013

J0485 Termination Date:

HCPCS Active

Nulojix billing and coding information can be found through Bristol Myers Squibb at the link below:
Nulojix patient assistance information can be found through Bristol Myers Squibb’s Patient Access Foundation at the URL: http://www.bmspaf.org
NULOJIX prescribing information can be found at the link below:
Information regarding NULOJIX’s side effects can be found at MedlinePlus